Tracking the Emergence of Azithromycin Resistance in Multiple Genotypes of Typhoidal Salmonella
Open Access
- 23 February 2021
- journal article
- research article
- Published by American Society for Microbiology in mBio
- Vol. 12 (1)
- https://doi.org/10.1128/mbio.03481-20
Abstract
The rising prevalence of antimicrobial resistance in Salmonella enterica serovars Typhi and Paratyphi A, causative agents of typhoid and paratyphoid, have led to fears of untreatable infections. Of specific concern is the emerging resistance against azithromycin, the only remaining oral drug to treat extensively drug resistant (XDR) typhoid. Since the first report of azithromycin resistance from Bangladesh in 2019, cases have been reported from Nepal, India, and Pakistan. The genetic basis of this resistance is a single point mutation in the efflux pump AcrB (R717Q/L). Here, we report 38 additional cases of azithromycin-resistant (AzmR) Salmonella Typhi and Paratyphi A isolated in Bangladesh between 2016 and 2018. Using genomic analysis of 56 AzmR isolates from South Asia with AcrB-R717Q/L, we confirm that this mutation has spontaneously emerged in different Salmonella Typhi and Paratyphi A genotypes. The largest cluster of AzmR Typhi belonged to genotype 4.3.1.1; Bayesian analysis predicts the mutation to have emerged sometime in 2010. A travel-related Typhi isolate with AcrB-R717Q belonging to 4.3.1.1 was isolated in the United Kingdom, increasing fears of global spread. For real-time detection of AcrB-R717Q/L, we developed an extraction-free, rapid, and low-cost mismatch amplification mutation assay (MAMA). Validation of MAMA using 113 AzmR and non-AzmR isolates yielded >98% specificity and sensitivity versus phenotypic and whole-genome sequencing assays currently used for azithromycin resistance detection. With increasing azithromycin use, AcrB-R717Q/L is likely to be acquired by XDR strains. The proposed tool for active detection and surveillance of this mutation may detect pan-oral drug resistance early, giving us a window to intervene. IMPORTANCE In the early 1900s, with mortality of ∼30%, typhoid and paratyphoid ravaged parts of the world; with improved water, sanitation, and hygiene in resource-rich countries and the advent of antimicrobials, mortality dwindled to acrB (AcrB-R717Q/L) in 2019, there have been increasing numbers of reports. Using genomics and Bayesian analysis, we illustrate that this mutation emerged in approximately 2010 and has spontaneously arisen multiple times. Emergence of pan-oral drug resistant Salmonella Typhi is imminent. We developed a low-cost, rapid PCR tool to facilitate real-time detection and prevention policies.Keywords
Funding Information
- Bill and Melinda Gates Foundation (INV-008335)
This publication has 42 references indexed in Scilit:
- Complete Genome Sequence of Salmonella enterica subsp. enterica Serovar Typhi P-stx-12Journal of Bacteriology, 2012
- Emergence of a Globally Dominant IncHI1 Plasmid Type Associated with Multiple Drug Resistant TyphoidPLoS Neglected Tropical Diseases, 2011
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Development and validation of a mismatch amplification mutation PCR assay to monitor the dissemination of an emerging variant ofVibrio choleraeO1 biotype El TorMicrobiology and Immunology, 2008
- BEAST: Bayesian evolutionary analysis by sampling treesBMC Evolutionary Biology, 2007
- Part I. Analysis of data gaps pertaining to Salmonella enterica serotype Typhi infections in low and medium human development index countries, 1984–2005Epidemiology and Infection, 2007
- Molecular Analysis of incHI1 Antimicrobial Resistance Plasmids from Salmonella Serovar Typhi Strains Associated with Typhoid FeverAntimicrobial Agents and Chemotherapy, 2003
- A HIGHLY CEFTRIAXONE-RESISTANT SALMONELLA TYPHI IN BANGLADESHThe Pediatric Infectious Disease Journal, 1999
- Impact of age and drug resistance on mortality in typhoid fever.Archives of Disease in Childhood, 1996
- Typhoid Fever Complicated by Intestinal Perforation: A Persisting Fatal Disease Requiring Surgical ManagementClinical Infectious Diseases, 1985